Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
出版年份 2016 全文链接
标题
Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 38, Pages 10661-10665
出版商
Proceedings of the National Academy of Sciences
发表日期
2016-09-07
DOI
10.1073/pnas.1612075113
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-GlobinGene
- (2016) Olivier Negre et al. HUMAN GENE THERAPY
- Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
- (2015) M. D. Hoban et al. BLOOD
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
- (2015) Peng Xu et al. Scientific Reports
- Safe mobilization of CD34+ cells in adults with -thalassemia and validation of effective globin gene transfer for clinical investigation
- (2014) F. Boulad et al. BLOOD
- Reactivation of Developmentally Silenced Globin Genes by Forced Chromatin Looping
- (2014) Wulan Deng et al. CELL
- Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 andpiggyBac
- (2014) Fei Xie et al. GENOME RESEARCH
- Targeted genome editing in human repopulating haematopoietic stem cells
- (2014) Pietro Genovese et al. NATURE
- Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free β-Thalassemia Induced Pluripotent Stem Cells
- (2013) Ning Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Reawakening fetal hemoglobin: prospects for new therapies for the -globin disorders
- (2012) D. E. Bauer et al. BLOOD
- Fetal hemoglobin in sickle cell anemia
- (2011) I. Akinsheye et al. BLOOD
- Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats
- (2011) M van der Burg et al. LEUKEMIA
- A Functional Element Necessary for Fetal Hemoglobin Silencing
- (2011) Vijay G. Sankaran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inability of Human Induced Pluripotent Stem Cell-Hematopoietic Derivatives to Downregulate MicroRNAs In Vivo Reveals a Block in Xenograft Hematopoietic Regeneration
- (2011) Ruth M. Risueño et al. STEM CELLS
- Population Estimates of Sickle Cell Disease in the U.S.
- (2010) Kathryn L. Hassell AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders
- (2009) D. A. Persons Hematology-American Society of Hematology Education Program
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific RepressorBCL11A
- (2008) Vijay G. Sankaran et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search